Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Nat Rev Drug Discov. 2014 Sep;13(9):692–708. doi: 10.1038/nrd4308

Figure 4. ‘Flat’ SARs.

Figure 4

The prototypical scaffold of BQCA (compound 8), which is an M1 muscarinic acetylcholine receptor PAM (positive allosteric modulator), was shown to possess a notoriously ‘flat’ or ‘shallow’ structure–activity relationship (SAR). An initial chemical-optimization effort afforded hundreds of analogues (including compound 9) in which R1 and R2 were not fluoro substituents that had very low success rate in potentiating M1-receptor-mediated calcium mobilization in cell lines (fewer than 5% of compounds were active). Application of the ‘fluorine walk’ identified multiple regions in which fluorine atoms were tolerated and improved M1-receptor potency, such as in compound 10. A subsequent re-optimization campaign with the optimal fluorine atoms in place was highly productive and led to the discovery of potent M1-receptor PAMs, such as compound 11. The inset summarizes the effects of modifications of different regions of the BCQA scaffold on different components of the PAM response. EC50, effector concentration for half-maximum response; pKB, dissociation constant.